Irritable bowel syndrome in the light of Rome consensus III (2006): 10 years later

Close metadata

Recommended articles:

Understanding similarities and differences of irritable bowel syndrome and conditions with IBS-like symptoms. Russian Journal of Evidence-Based Gastroenterology. 2024;(1):66-78

Clinical and epidemiological features of atopic type of alopecia areata. Russian Journal of Clinical Dermatology and Venereology. 2024;(2):155-160

Traumatic damage to the diaphragm in children. Pirogov Russian Journal of Surgery. 2024;(4):64-68

Features of smoking in modern urban school adolescents. Russian Journal of Preventive Medicine. 2024;(4):52-59

Promising approaches to the pathogenetic therapy of amyotrophic lateral sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):13-21

Long-term follow-up of adult patients with serial and status course of epileptic seizures. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):63-68

Prevalence of cognitive impairment in older adults in the Russian Federation. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):5-11

Efficacy and safety of choline alfoscerate in the preventive therapy of dementia in elderly patients with Mild Cognitive Impairment: a three-year prospective comparative study. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):92-99

Use of systemic steroids in hospitalized patients with COVID-19. Russian Journal of Preventive Medicine. 2024;(5):75-80

Our experience in the treatment of congenital nasal median heterotopias in children and an overview of various treatment tactics. Russian Bulletin of Otorhinolaryngology. 2024;(2):28-32

Irritable bowel syndrome (IBS) is the most common diagnosis in gastroenterology. Over 10 years after Rome consensus III (2006), there has been much new information on the pathogenesis of IBS and its therapy options. The paper analyzes basic investigations that have contributed to the theory of this disease and to a better quality of life in patients.

Keywords:

irritable bowel syndrome

Rome criteria

prevalence

comorbidity

gene polymorphisms

food factors

postinfectious irritable bowel syndrome

sex hormones

FODMAP diet

treatment

Authors:

Parfenov A.I.

GBUZ "Moskovskiĭ klinicheskiĭ nauchno-prakticheskiĭ tsentr" Departamenta zdravookhraneniia Moskvy

Albulova E.A.

Moscow Clinical Research and Practical Center, Moscow Healthcare Department, Moscow, Russia

Ruchkina I.N.

GBUZ "Moskovskiĭ klinicheskiĭ nauchno-prakticheskiĭ tsentr" Departamenta zdravookhraneniia Moskvy

List of references:

Maev I.V., Kucheryavyi Yu.A., Cheremushkin S.V. Evolyutsiya predstavlenii o sindrome razdrazhennogo kishechnika. M.; 2013.
Liu J, Wei X, Zhao C, Hu S, Duan J, Ju G, Wong-Riley MT, Liu Y. 5-HT induces enhanced phrenic nerve activity via 5-HT2A receptor/PKC mechanism in anesthetized rats. Eur J Pharmacol. 2011;657:67-75. doi:10.1016/j.ejphar.2011.01.048.
Hua MC, Chao HC, Yao TC, Lai MW, Huang JL. Investigation of interleukin-10 promoter polymorphisms and interleukin-10 levels in children with irritable bowel syndrome. Gut Liver. 2013;7:430-436. doi:10.5009/gnl.2013.7.4.430.
Saito YA, Larson JJ, Atkinson EJ, Ryu E, Almazar AE, Petersen GM, Talley NJ. The role of 5-HTT LPR and GNβ3 825C& gt; T polymorphisms and gene-environment interactions in irritable bowel syndrome (IBS). Dig Dis Sci. 2012;57:2650-2657. doi:10.1111/apt.13094.
Clarke G, Fitzgerald P, Cryan JF, Cassidy EM, Quigley EM, Dinan TG. Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3-dioxygenase activation in a male cohort. BMC Gastroenterol. 2009;9:6-9. doi:10.1186/1471-230x-9-6.
Coutinho SV, Plotsky PM, Sablad M, Li Y, Nie Y, Xie J et al. The association of serotonin transporter genetic polymorphisms and irritable bowel syndrome and its influence on tegaserod treatment in Chinese patients. Dig Dis Sci. 2000;52:2942-2949.
Drossman DA. The Functional Gastrointestinal Disorders and the Rome III Process. Gastroenterology. 2006;130(5):1377-1390. doi:10.5056/jnm15016.
Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology. 2009;136(6):1979-1988. doi:10.1111/nmo.12529.
Parfenov A.I., Ruchkina I.N., Ataullakhanov R.I., Belaya O.F., Chikunova B.Z., Pichugin A.F., Kozhemyakina E.Sh. Postinfektsionnyi sindrom razdrazhennogo kishechnika. Terapevticheskii arkhiv. 2009;81(2):39-45.
Parfenov A.I., Ruchkina I.N. Postinfektsionnyi sindrom razdrazhennogo kishechnika. Lechashchii vrach. 2010;7:16-19.
Hong SN, Rhee PL. Unraveling the ties between irritable bowel syndrome and intestinal microbiota. World J Gastoenterol. 2014;20(10):2470-2481. doi:10.4166/kjg.2015.66.4.202.
Lee YJ, Park KS. Irritable bowel syndrome: emerging paradigm in pathophysiology. World J Gastroenterol. 2014;20(10):2456-2469. doi:10.1097/md.0000000000001934.
Parfenov A.I. Enterologiya. Izd. 2-e. M.: Meditsinskoe informatsionnoe agentstvo; 2009.
Gracie DJ, Ford AC. IBS-like symptoms in patients with ulcerative colitis. Clin Exper Gastroenterol. 2015;8:101-109. doi:10.1053/j.gastro.2015.09.024.
El-Serag HB, Pilgrim P, Schoenfeld P. Systemic review: natural history of irritable bowel syndrome. Aliment Pharmacol Ther. 2004;19(8):861-870. doi:10.1111/j.1365-2036.2004.01929.x.
Everhart JE, Ruhl CE. Burden of digestive diseases in the United States, part II: lower gastrointestinal diseases. Gastroenterology. 2009;136(3):741-754. doi:10.1053/j.gastro.2009.01.015.
Chey WD, Kurlander J, Eswaran S. Irritable Bowel Syndrome. A Clinical Review JAMA. 2015;313(9):949-958. doi:10.1001/jama.2015.0954.
Shepherd SJ, Parker FC, Muir JG, Gibson PR. Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin Gastroenterol Hepatol. 2008;6(7):765-771. doi:10.1016/j.cgh.2008.02.058.
Carroccio A, Mansueto P, D’Alcamo A, Iacono G. Non-celiac wheat sensitivity as an allergic condition: personal experience and narrative review. Am J Gastroenterol. 2013;108(12):1845-1852. doi:10.1038/ajg.2013.353.
Sapone A, Bai JC, Ciacci C, Dolinsek J, Green PH, Hadjivassiliou M, Kaukinen K, Rostami K, Sanders DS, Schumann M, Ullrich R, Villalta D, Volta U, Catassi C, Fasano A. Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med. 2012;10:13-24. doi:10.1186/1741-7015-10-13.
Biesiekierski JR, Newnham ED, Shepherd SJ, Muir JG, Gibson PR. Characterization of adults with a self-diagnosis of nonceliac gluten sensitivity. Nutr Clin Pract. 2014;29(4):504-509. doi:10.1177/0884533614529163.
Vazquez-Roque MI, Camilleri M, Smyrk T, Murray JA, Marietta E, O’Neill J, Carlson P, Lamsam J, Janzow D, Eckert D, Burton D, Zinsmeister AR. A controlled trial of gluten-free diet in patients with irritable bowel syndrome diarrhea: effects on bowel frequency and intestinal function. Gastroenterology. 2013;144(5):903-911. doi:10.1053/j.gastro.2013.01.049.
Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology. 2014;146(1):67-75. doi:10.1053/j.gastro.2013.09.046.
Palomba S, Di Cello A, Riccio E, Manguso F, La Sala GB. Ovarian function and gastrointestinal motor activity. Minerva Endocrinol. 2011;36:295-310.
Guarino M, Cheng L, Cicala M, Ripetti V, Biancani P, Behar J. Progesterone receptors and serotonin levels in colon epithelial cells from females with slow transit constipation. Neurogastroenterol Motil. 2011;23(6):575-e210. doi:10.1111/j.1365-2982.2011.01705.x.
Labus JS, Dinov ID, Jiang Z, Ashe-McNalley C, Zamanyan A, Shi Y, Hong JY, Gupta A, Tillisch K, Ebrat B, Hobel S, Gutman BA, Joshi S, Thompson PM, Toga AW, Mayer EA. Irritable bowel syndrome in female patients is associated with alterations in structural brain networks. Pain. 2014;155(1):137-149. doi:10.1016/j.pain.2013.09.020.
Cunningham M, Gilkeson G. Estrogen receptors in immunity and autoimmunity. Clin Rev Allergy Immunol. 2011;40(1):66-73. doi:10.1007/s12016-010-8203-5.
Lazaraki G, Chatzimavroudis G, Katsinelos P. Recent advances in pharmacological treatment of irritable bowel syndrome. World J Gastroenterol. 2014;20(27):8867-8885. doi:10.3748/wjg.v20.i27.8867.
Corinaldesi R, Stanghellini V, Cremon C, Gargano L, Cogliandro RF, De Giorgio R, Bartesaghi G, Canovi B, Barbara G. Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proofof-concept study. Aliment Pharmacol Ther. 2009;30(3):245-252. doi:10.1111/j.1365-2036.2009.04041.x.
Andrews CN, Griffiths TA, Kaufman J, Vergnolle N, Surette MG, Rioux KP. Mesalazine (5-aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2011;34(3):374-383. doi:10.1111/j.1365-2036.2011.04732.x.
Drossman DA, Chey WD, Johanson JF, Fass R, Scott C, Panas R, Ueno R. Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome-results of two randomized, placebo-controlled studies. Aliment Pharmacol Ther. 2009;29(3): 329-341. doi:10.1111/j.1365-2036.2008.03881.x.
Johnston JM, Kurtz CB, Macdougall JE, Lavins BJ, Currie MG, Fitch DA, O’Dea C, Baird M, Lembo AJ. Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome with constipation. Gastroenterology. 2010; 139(6):1877-1886. doi:10.1053/j.gastro.2010.08.041.
Rao S, Lembo AJ, Shiff SJ, Lavins BJ, Currie MG, Jia XD, Shi K, MacDougall JE, Shao JZ, Eng P, Fox SM, Schneier HA, Kurtz CB, Johnston JM. A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation. Am J Gastroenterol. 2012;107:1714-1724. doi:10.1038/ajg.2012.255.
Epshtein O.I. Sverkhmalye dozy (istoriya odnogo issledovaniya). M.: Izdatel'stvo RAMN; 2008.
Ertuzun I.A., Zueva E.P., Krylova S.G., Efimova L.A., Dugina Yu.L., Epshtein O.I. Eksperimental'noe izuchenie «Koloforta» — novogo preparata dlya lecheniya sindroma razdrazhennogo kishechnika i drugikh funktsional'nykh zabolevanii zheludochno-kishechnogo trakta. Vestnik VolgGMU. 2012;4:25-27.
Avalueva E.B., Adasheva T.V., Babaeva A.R., Burdina E.G., Kireeva N.V., Lenskaya L.G., Osadchuk M.A., Pakhomova I.G., Popova L.I., Tkachenko E.I., Uspenskii Yu.P., Shvarts Yu.G., Myslivets A.A., Andrianova E.N. Effektivnost' i bezopasnost' primeneniya Koloforta pri sindrome razdrazhennogo kishechnika: itogi mnogotsentrovogo dvoinogo slepogo platsebo-kontroliruemogo randomizirovannogo klinicheskogo issledovaniya. Gastroenterologiya. 2014;1:43-50.
Maev I.V., Cheremushkin S.V., Kucheryavyi Yu.A., Cheremushkina N.V. Farmakoterapiya sindroma razdrazhennogo kishechnika s pozitsii dokazatel'noi meditsiny. Terapevticheskii arkhiv. 2015;2:5-10.

Close metadata